Background {#Sec1}
==========

Due to the property of rapid onset and recovery, remifentanil is quite widely used in clinic. However, remifentanil was reported to be associated with the development of hyperalgesia. it was noted that general anesthesia based on remifentanil infusion resulted in severe postoperative pain after surgery \[[@CR1]\]. Additionally, analgesic consumption after operation can be increased following the intraoperative use of remifentanil \[[@CR2]\].

N-methyl-D aspartate (NMDA) receptors was known to play a critical role in excitatory synaptic transmission. Remifentanil could enhance the activation of spinal NMDA receptor, which was attributed to the progress of remifentanil induced hyperalgesia (RIH) \[[@CR3]\].

NR~2~B subunit is an essential part in the NMDA receptors. Tyrosine-1472 phosphorylation in NR~2~B is known to be associated with neuropathological conditions \[[@CR4]\]. Phosphorylation of Tyr-1472 in NR~2~B (pNR~2~B) has previously been demonstrated in the progress of RIH \[[@CR5]\].

NMDA receptor antagonist was implicated to decrease the extended area of RIH in human \[[@CR6]\]. Prior administration of magnesium could inhibit delayed fentanyl induced hyperalgesia \[[@CR7], [@CR8]\] in rats. Our previous study suggested that magnesium sulphate could dose-dependently inhibit RIH in rats \[[@CR9]\]. The purpose of this study was to explore whether intrathecal magnesium administration could prevent RIH via decreasing the amount of pNR~2~B expression in superficial dorsal horn of spinal cord.

Methods {#Sec2}
=======

Animals {#Sec3}
-------

After approval of experimental animal center of Wenzhou Medical university, Adult male Sprague--Dawley rats (230 ± 30 g) were obtained and maintained under a 12 h light −12 h dark cycle with food and water freely available.

Intrathecal catheter placement {#Sec4}
------------------------------

Intrathecally catheterization was performed after an acclimation period of at least 5 days for the rats. Under sevoflurane anesthesia, plastic PE-10 tube (OD: 0.5 mm, ID: 0.25 mm, AniLab Co. Ltd, China) was implanted into intrathecal space. The rostral part of the catheter was then sutured to the muscle to immobilize it.

Surgical procedure {#Sec5}
------------------

Under sevoflurane anesthesia, a longitudinal incision (0.8 cm) was made starting from edge of the heel and extending toward the toes of the right hind paw. The underlying plantaris muscle was exposed and incised longitudinally, leaving the muscle origin and insertion intact. After hemostasis, skin was closed covered with antiseptic gauze.

Remifentanil infusion {#Sec6}
---------------------

Remifentanil (1.2 μg.kg^−1^.min^−1^) was infused via tail vein over a period of 60 min using a pump.

Behavioral test {#Sec7}
---------------

Mechanical nociception was determined by measuring paw withdrawal mechanical thresholds (PWMT). Through a mesh bottom (1 × 1 cm), the electronic von Frey filament (0.8 mm diameter, LS instrument, USA) was applied vertically to the plantar surface of the right hind paw. Positive nociceptive-like response was defined as clear paw withdrawal or licking.

Thermal nociception was determined by measuring paw withdrawal thermal latency (PWTL) using thermal stimulation system (Model 336, Series 8, IITC INC, USA). A radiant thermal source below a glass floor (5 mm thick) was positioned to deliver a thermal stimulus to the midplantar region adjacent to the wound of right hind paw. When the rat had response of clear paw withdrawal or flinching, the thermal source was switched off, and the timer stopped, measuring the PWTL. Thermal stimulation was automatically cut off after 25 s if the rat fails to withdraw.

Animals were allowed to acclimatize for 30 min before testing. Mean PWTL and PWMT were established by averaging the values of three tests with a five minute interval between each test.

Drugs {#Sec8}
-----

Remifentanil hydrochloride (Ultiva) (batch number: 6587129, Ren Fu Co, China), Magnesium sulfate (M2643, Sigma. St. Louis, USA), sevoflurane (batch number: 4Z132, maruishi-pharm.co. Japan).

Western blotting {#Sec9}
----------------

After the last behavioral test, the animals were sacrificed with sevoflurane and lumbar spinal cord L~4~-L~5~ segments were removed in 2 min. Tissue samples were homogenized in lysis buffer containing protease inhibitors (Sigma-Aldrich Co.). The homogenate was centrifuged at 12,000 rpm for 5 min at 4 °C and supernatant was removed as the total protein. Proteins (70 μg) were separated on a 7.5% sodium dodecyl sulfate--polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride membrane (Bio-Rad, CA) with a Trans-Blot Transfer Cell system (Bio-Rad, CA). The filters were blocked with 5% nonfat milk in TBS buffer at room temperature for 1 h. Then the blot was incubated with the primary antibody against phosphorylated Tyr 1472 NR~2~B (1:1000; Cell signaling Technology, USA) overnight at 4 °C. The membrane was washed with TBS buffer and incubated for 1 h with the secondary anti- rabbit IgG horseradish peroxidase (1:2000; Jackson ImmunoResearch, USA) at room temperature and visualized in enhanced chemiluminescence solution (Amersham Biosciences) followed by film exposure. β-Actin was used as endogenous control (1:10,000, Biotechnology, USA). Those who did the western blot were blinded to the group allocation. Densitometric quantification of each specific band was performed using Gene Tools Match software (Syngene, Cambridge, UK). The results were expressed as the percentage of β-actin immunoreactivity.

Experiment protocol {#Sec10}
-------------------

Experiments were performed 7 days later after intrathecal catheterization. To evaluate thermal and mechanical hyperalgesia induced by remifentanil, 32 rats were assigned into the following four experimental groups (*n* = 8): 1: Group C (a control group with the administration of sevoflurane inhalation without incision); 2: Group RI (model of RIH with surgical procedure and remifentanil infusion, 10 μl normal saline was intrathecally administration); 3: Group RIM~3~ (300 μg MgSO~4~ was intrathecally given to the group RI); 4: Group RIM~1~ (100 μg MgSO~4~ was intrathecally given to the group RI). 30 min before remifentanil infusion and plantar incision, MgSO~4~ or normal saline were intrathecally administration in a volume of 10 μl, followed by additional normal saline (20 μl) to flush the catheter. Remifentanil infusion and plantar incision were performed at the same time. PWMT and PWTL tests were performed at −24 h, 2 h, 6 h, 24 h, and 48 h after remifentanil infusion. The L~4~-L~5~ segments for western blot analysis were collected just after behavioral testing at 48 h to investigate whether magnesium could prevent RIH via modulating spinal pNR~2~B activity.

All behavioral tests were carried out in a quiet test room by the same investigator (Doc Lin) who was blinded to the group allocation.

Statistical analysis {#Sec11}
--------------------

Quantitative parametric data obtained from the groups were expressed as mean ± SD. Data from thermal and mechanical hyperalgesia were analyzed using repeated measures analysis of variance. The expression of pNR~2~B across all experimental groups were statistically tested by one-way ANOVA with Bonferroni correction. The level of statistical significance was set at *p* = 0.05. Data were analyzed with the SPSS 15.0 software (SPSS Inc., Chicago, IL, USA).

Result {#Sec12}
======

There were no statistical differences by the basal PWTL and PWMT values among the experimental groups (*p* \> 0.05).

Compared with normal saline, both of 300 μg and 100 μg MgSO4 significantly inhibited thermal (Fig. [1a](#Fig1){ref-type="fig"}) and mechanical (Fig. [1b](#Fig1){ref-type="fig"}) hyperalgesia. Compared with 100 μg MgSO~4~, 300 μg MgSO~4~ had less thermal hyperalgesia at 2 h, 6 h, 24 h, 48 h (*p* = 0.000) and less mechanical hyperalgesia at 2 h (*p* = 0.009),6 h (*p* = 0.005), 24 h (*p* = 0.004). There was no statistical difference in mechanical hyperalgesia at 48 h (*p* = 0.286) (Fig. [1](#Fig1){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}).Fig. 1**a**-**b** Effect of MgSO~4~ on remifentanil-induced hyperalgesia. MgSO~4~ or normal saline were administered intrathecally 30 min before remifentanil infusion and surgical incision. PWTL (**a**) and PWMT (**b**) were evaluated at 24 h before incision and 2, 6, 24, 48 h. Data are expressed as means ± SD. \* *p* \< 0.001 compared with Group C, ^\#^ *p* \< 0.001 compared with Group RI, ^+^ *p* \< 0.01 compared with GroupRIM~1~

The levels of tyrosine phosphorylated NR~2~B of NMDA receptors were significantly lower in GroupRIM~3~ compared with the levels in GroupRIM~1~ and Group RI (*p* \< 0.001). No significant change was detected between GroupRIM~3~ and Group C (*p* = 0.078). (Fig. [2](#Fig2){ref-type="fig"}, Additional file [2](#MOESM2){ref-type="media"}).Fig. 2**a**-**b** The expression level of tyrosine phosphorylation of NR~2~B in superficial spinal cord in each group. L~4~-L~5~ segments of spinal cord were collected at 48 h after the remifentanil infusion. **a** Bands of Western blot for pNR~2~B. β-Actin is a loading control. **b** Quantification of pNR~2~B in each group. Data are expressed as means ± SD. \* *p* \< 0.001 compared with Group RI, ^\#^ *p* \< 0.001 compared with Group RIM~1~

Discussion and conclusions {#Sec13}
==========================

In the current study, remifentanil was found to aggravate both mechanical and thermal hyperalgesia after remifentanil infusion. Intrathecal Mg^2+^ provided a dose-dependent anti-nociceptive effect \[[@CR10]\]. The authors have previously demonstrated that the MgSO~4~ doses of 100ug and 300 μg were safe for intrathecal injection in rats \[[@CR9]\]. MgSO~4~ was reported to alleviate the hyperalgesia via inhibiting the tyrosine phosphorylation of NMDA receptor in dorsal horn of lumber spinal cord \[[@CR11]\].

Remifentanil was report to induce dose-dependent hyperalgesia in human \[[@CR2]\]. The hyperalgesic effect of opioid was complicated and was once seemed to be mediated by opioid receptors. However, hyperalgesia could still be provoked by opioid in mice in which μ, κ and δ opioid receptors were completely knocked out \[[@CR12], [@CR13]\]. On the contrary, infusing the opioid could still cause hyperalgesia instead of analgesia in these knockout mice \[[@CR13]\]. Based on the results of these studies, it is supposed that opioid-induced hyperalgesia may be explained by mechanism other than opioid receptors.

MgSO~4~ in the trial was found to decrease the remifentanil induced hyperalgesia. RIH may be associated with NMDA activation via an intracellular pathway to up-regulate the function of NMDA activity \[[@CR3]\]. MgSO~4~ could occlude the Ca^2+^ ion current, which resulted in a further release of glutamate and initiating a series of central sensitization to induce opioid-induced hyperalgesia \[[@CR14], [@CR15]\]. As illustrated by Angst's study, even short-term administration of remifentanil could enhance hyperalgesia during withdrawal, while ketamine, the NMDA receptor antagonist, could abolish such hyperalgesic response \[[@CR6]\]. NMDA antagonists could reverse opioid hyperalgesia by antagonizing NMDA receptors \[[@CR16]\]. Taken together, NMDA palyed a key role in pathogenesis of RIH.

Distribution of NMDA receptor NR~2~B was demonstrated to almost limit in the superficial dorsal horn \[[@CR17]\]. The spinal sensitization and increased nociceptive input may present due to the condition that noxious stimulus occurred within the superficial dorsal horn in the central primary afferent terminals. Subsequently, nociceptive substances such as glutamic acids activate the specific nociceptive neurons and create the pain impulses. Following such injury, the expression of NR~2~B subunit in superficial dorsal horn was detected to increase significantly \[[@CR18]\].

Protein phosphorylation is a major mechanism for the regulation of receptor activity. Tyr-1472 phosphorylation of NR~2~B subunit is important for synaptic plasticity and the development of central sensitization \[[@CR19]\]. Furthermore, tyr-1472 phosphorylation in the superficial dorsal horn of the spinal cord contributed to the progress of hyperalgesia in neuropathic pain \[[@CR20], [@CR21]\]. Abrupt withdrawal from opioid use could activate NMDA receptors and increase postsynaptic calcium concentrations \[[@CR22]\]. NMDA antagonist was found to block increased Tyr1472 phosphorylation and inhibit remifentanil induced hyperalgesia \[[@CR23]\].

Mg deficiency could facilitate NMDA receptor activation and long-term sensitization of the nociceptive pathways \[[@CR11]\]. Previous study has showed that intrathecal administration of MgSO~4~ was beneficial in rats with NMDA receptor-dependent hyperalgesia \[[@CR15]\].

Our findings support our hypothesis that NR~2~B tyrosine phosphorylation could be alleviated by NMDA antagonists. However, direct evidence of magnesium to the NR~2~B tyrosine phosphorylation and hyperalgesia remains to be further explored. It is the first study to demonstrate that magnesium could prevent RIH via decreasing Tyr-1472 phosphorylation in NMDA receptor.

Sevoflurane was previously proved to have no influence on nociceptive thresholds, so it was used for anesthesia and animal sacrifice in this study \[[@CR24]\]. The doses of MgSO~4~ employed in the trial was based on the previous study \[[@CR9]\]. Limitations:NMDA receptors are positioned in either cellular membrane or cytoplasm. In the previous study, it was demonstrated that membrane trafficking of NR~2~B subunits in the spinal cord were significantly promoted after remifentanil infusion \[[@CR25]\]. Due to inadequate funding, we only extracted the total protein for western blot analysis. In the further study, we should extract the membrane protein of dorsal horn to detect the amount of pNR~2~B subunits after magnesium intervention.Sole surgical incision can also induce hyperalgesia after operation. Why the hyperalgesia in the paper was attributed to the remifentanil infusion? Previous report from our research have demonstrated that remifentanil infusion alone could trigger more severe hyperalgesia than surgical incision alone \[[@CR9]\]. In the figure, the experiment indicated that MgSO~4~ could inhibit RIH with statistical difference. However, in the Group RIM~3~ and Group RIM~1~, the thresholds of the behavior tests in the Fig. [1](#Fig1){ref-type="fig"} were found to have the same level compared with the thresholds in the Group surgical incision alone in the figure (shown as Additional file [1](#MOESM1){ref-type="media"}). In the incision-absent group, it is virtually impossible to interpret our results. In order to present the result, we uploaded a new Figure as (shown as Additional files [3](#MOESM3){ref-type="media"} and [4](#MOESM4){ref-type="media"}) which combined the Group magnesium in the study and the Group single incision from the model experiment in our previous study \[[@CR9]\]. Both of the two study were performed by doc Sun at the same condition. Maybe we have made over-interpretation of the data. It was afraid that such differences did not have clinically meaningful. In conclusion, the increased expression of NR~2~B phosphorylation in the spinal dorsal horn played an important role in the progress of RIH. Intrathecal administration of MgSO~4~ could dose-dependently diminish RIH via decreasing the amount of pNR~2~B in the spinal dorsal horn. This study offered the potential therapeutic opportunities of MgSO~4~ for the management of opioid induced pain.
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